Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Martek Nutritional Oils Addition To U.S. Infant Formulas Forthcoming

This article was originally published in The Tan Sheet

Executive Summary

FDA's long-awaited affirmation that Martek Biosciences' nutritional oils are generally recognized as safe came May 17, giving the firm an entry into the approximately $2 bil. U.S. infant formula market.

You may also be interested in...



Science-Based Ingredient Firms Spur Bullish Investors In Supplement Sector

Buying trends of private equity firms show that ingredient companies are expected to drive growth in the nutritional supplement industry, according to Adams Harkness managing director David Thibodeau

Science-Based Ingredient Firms Spur Bullish Investors In Supplement Sector

Buying trends of private equity firms show that ingredient companies are expected to drive growth in the nutritional supplement industry, according to Adams Harkness managing director David Thibodeau

Science-Based Ingredient Firms Spur Bullish Investors In Supplement Sector

Buying trends of private equity firms show that ingredient companies are expected to drive growth in the nutritional supplement industry, according to Adams Harkness managing director David Thibodeau

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092570

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel